Asphalion brings science to the market through regulation compliance. Asphalion is partner of the consortium of iHIVARNA project. iHIVARNA strategy proposes using an mRNA?based therapeuticvaccine encoding HIV antigens as a novel and promising approachin HIV immunotherapy #H2020projects
Brexit updates for human use medicinal products approved via MRP/DCP
As Brexit is quickly coming closer, the CMDh has published an updated version of the Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP in December 2020.